GlassScriptPhysician profile
Anu Anna George
NPI 1144839879
$1,566.04
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $42.12 · 2021: $449 · 2022: $638 · 2023: $269 · 2024: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $286.32 | 2020-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $275.03 | 2021-2023 | Opdivo, Camzyos |
| Astrazeneca Pharmaceuticals LP | $202.69 | 2021-2024 | Airsupra |
| Abbvie INC. | $161.27 | 2021-2023 | |
| Gilead Sciences, INC. | $122.52 | 2021-2024 | |
| Alexion Pharmaceuticals, INC. | $116.09 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.95 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.52 | 2020-2022 | |
| Abiomed | $52.34 | 2023-2024 | Impella |
| Pfizer INC. | $45.58 | 2020-2024 | |
| Viiv Healthcare Company | $31.66 | 2023 | Dovato |
| Alcresta Therapeutics, INC. | $24.44 | 2022 | |
| Baxter Healthcare | $21.36 | 2024 | |
| Incyte Corporation | $19.26 | 2021 | |
| Novo Nordisk INC | $19.03 | 2024 | Ozempic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.45 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.69 | 2021 | |
| Glaxosmithkline, LLC. | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anu George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.